Sign Up for a Free Account
  • Updated 09.12.2024
  • Released 06.11.2001
  • Expires For CME 09.12.2027

Atrial myxoma

Introduction

Overview

Atrial myxoma, the most common intracardiac tumor in adults, may cause cardiac dysfunction, embolic stroke, and systemic manifestations that mimic infective, immunologic, and malignant diseases. Several associated cutaneous syndromes may facilitate timely recognition. Its various clinical manifestations make clinical diagnosis difficult. Approximately 60% of all tumors are diagnosed by echocardiogram. The definitive treatment is surgical excision. Potentially life-threatening, atrial myxomas require prompt diagnosis and urgent treatment.

Key points

• Atrial myxoma is the most common intracardiac tumor. Although benign, its central location often results in significant morbidity and mortality.

• Myxomas have a wide variety of cardiac, embolic, and systemic manifestations, including paraneoplastic syndromes.

• No guidelines for acute ischemic stroke caused by atrial myxoma embolism treatment have been published.

• Intravenous thrombolysis within a 3-hour window was successful in patients with acute stroke caused by myxoma.

• Hemorrhagic complications after thrombolysis may be due to recent, undiagnosed infarcts or aneurysms.

• Intra-arterial recanalization is effective in patients with large artery occlusion due to myxoma embolization.

Historical note and terminology

Left atrial myxoma was first described in the 19th century (76) and was diagnosed by angiocardiography in 1952 (79). The first surgical excision occurred three years later (30).

The first non-embolic dermatologic manifestation of atrial myxoma was described in 1973 as the nevus, atrial myxoma, myxoid neurofibromata, and ephelides or endocrine hyperactivity (NAME syndrome). Later, it was described as the lentigines, atrial myxoma, and blue nevi (LAMB syndrome); Carney complex (atrial myxoma associated with multiple neoplasia lentigines) was also reported (51). Sneddon syndrome, which commonly presents with a livedo-type rash and diffuse cerebrovascular disease, has also been associated with atrial myxoma (152).

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125